{"id":"https://openalex.org/W4310045802","doi":"https://doi.org/10.1186/s12885-022-10216-z","title":"TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma","display_name":"TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma","publication_year":2022,"publication_date":"2022-11-24","ids":{"openalex":"https://openalex.org/W4310045802","doi":"https://doi.org/10.1186/s12885-022-10216-z","pmid":"https://pubmed.ncbi.nlm.nih.gov/36434554","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9700963"},"language":"en","primary_location":{"id":"doi:10.1186/s12885-022-10216-z","doi":"https://doi.org/10.1186/s12885-022-10216-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-022-10216-z","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-022-10216-z","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-022-10216-z","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057264839","display_name":"Elodie Coquan","orcid":"https://orcid.org/0000-0002-9497-0424","observed_orcids":["https://orcid.org/0000-0002-9497-0424"]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Elodie Coquan","raw_affiliation_strings":["Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France. e.coquan@baclesse.unicancer.fr","Medical Oncology Department, Centre Fran\u00e7ois Baclesse, 3 Avenue du G\u00e9n\u00e9ral Harris, 14076, Caen Cedex 05, France. e.coquan@baclesse.unicancer.fr","Medical Oncology Department, Centre Fran\u00e7ois Baclesse, 3 Avenue du G\u00e9n\u00e9ral Harris, 14076, Caen Cedex 05, France"],"raw_orcid":"https://orcid.org/0000-0002-9497-0424","affiliations":[{"raw_affiliation_string":"Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France. e.coquan@baclesse.unicancer.fr","institution_ids":["https://openalex.org/I4210121964"]},{"raw_affiliation_string":"Medical Oncology Department, Centre Fran\u00e7ois Baclesse, 3 Avenue du G\u00e9n\u00e9ral Harris, 14076, Caen Cedex 05, France. e.coquan@baclesse.unicancer.fr","institution_ids":["https://openalex.org/I4210121964"]},{"raw_affiliation_string":"Medical Oncology Department, Centre Fran\u00e7ois Baclesse, 3 Avenue du G\u00e9n\u00e9ral Harris, 14076, Caen Cedex 05, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028829159","display_name":"B\u00e9n\u00e9dicte Clarisse","orcid":"https://orcid.org/0000-0002-0543-732X","observed_orcids":["https://orcid.org/0000-0002-0543-732X"]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B\u00e9n\u00e9dicte Clarisse","raw_affiliation_strings":["Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031850292","display_name":"Justine Lequesne","orcid":"https://orcid.org/0000-0001-7046-1003","observed_orcids":["https://orcid.org/0000-0001-7046-1003"]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Justine Lequesne","raw_affiliation_strings":["Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113852754","display_name":"Pierre-Emmanuel Brachet","orcid":"https://orcid.org/0000-0003-3303-2634","observed_orcids":["https://orcid.org/0000-0003-3303-2634"]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre-Emmanuel Brachet","raw_affiliation_strings":["Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France","Medical Oncology Department, Centre Fran\u00e7ois Baclesse, 3 Avenue du G\u00e9n\u00e9ral Harris, 14076, Caen Cedex 05, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France","institution_ids":["https://openalex.org/I4210121964"]},{"raw_affiliation_string":"Medical Oncology Department, Centre Fran\u00e7ois Baclesse, 3 Avenue du G\u00e9n\u00e9ral Harris, 14076, Caen Cedex 05, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008268754","display_name":"Zo\u00e9 Nevi\u00e8re","orcid":"https://orcid.org/0000-0002-7513-9125","observed_orcids":["https://orcid.org/0000-0002-7513-9125"]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Zo\u00e9 Nevi\u00e8re","raw_affiliation_strings":["Medical Oncology Department, Centre Fran\u00e7ois Baclesse, 3 Avenue du G\u00e9n\u00e9ral Harris, 14076, Caen Cedex 05, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Centre Fran\u00e7ois Baclesse, 3 Avenue du G\u00e9n\u00e9ral Harris, 14076, Caen Cedex 05, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040394407","display_name":"\u00c9meline Meriaux","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Emeline Meriaux","raw_affiliation_strings":["Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France","Medical Oncology Department, Centre Fran\u00e7ois Baclesse, 3 Avenue du G\u00e9n\u00e9ral Harris, 14076, Caen Cedex 05, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France","institution_ids":["https://openalex.org/I4210121964"]},{"raw_affiliation_string":"Medical Oncology Department, Centre Fran\u00e7ois Baclesse, 3 Avenue du G\u00e9n\u00e9ral Harris, 14076, Caen Cedex 05, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Isabelle Bonnet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Isabelle Bonnet","raw_affiliation_strings":["Medical Oncology Department, Centre Fran\u00e7ois Baclesse, 3 Avenue du G\u00e9n\u00e9ral Harris, 14076, Caen Cedex 05, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Centre Fran\u00e7ois Baclesse, 3 Avenue du G\u00e9n\u00e9ral Harris, 14076, Caen Cedex 05, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108826583","display_name":"Marie Cast\u00e9ra","orcid":"https://orcid.org/0009-0005-7674-6778","observed_orcids":["https://orcid.org/0009-0005-7674-6778"]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marie Castera","raw_affiliation_strings":["Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011949577","display_name":"Nicolas Goardon","orcid":"https://orcid.org/0000-0002-5093-0922","observed_orcids":["https://orcid.org/0000-0002-5093-0922"]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicolas Goardon","raw_affiliation_strings":["Genetic and Oncology Biology Department, Centre Fran\u00e7ois Baclesse, 14076, Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genetic and Oncology Biology Department, Centre Fran\u00e7ois Baclesse, 14076, Caen, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009640398","display_name":"J\u00e9r\u00e9my Boutrois","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jeremy Boutrois","raw_affiliation_strings":["Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016517519","display_name":"Romain Travers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Romain Travers","raw_affiliation_strings":["Northwest Data Center (CTD-CNO), Centre Fran\u00e7ois Baclesse, 14076, Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwest Data Center (CTD-CNO), Centre Fran\u00e7ois Baclesse, 14076, Caen, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042461515","display_name":"Florence Joly","orcid":"https://orcid.org/0000-0001-7004-9895","observed_orcids":["https://orcid.org/0000-0001-7004-9895","https://orcid.org/0000-0001-6168-4942","https://orcid.org/0000-0001-8018-6359"]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Florence Joly","raw_affiliation_strings":["Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France","Medical Oncology Department, Centre Fran\u00e7ois Baclesse, 3 Avenue du G\u00e9n\u00e9ral Harris, 14076, Caen Cedex 05, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France","institution_ids":["https://openalex.org/I4210121964"]},{"raw_affiliation_string":"Medical Oncology Department, Centre Fran\u00e7ois Baclesse, 3 Avenue du G\u00e9n\u00e9ral Harris, 14076, Caen Cedex 05, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015165342","display_name":"Jean\u2010Michel Grellard","orcid":"https://orcid.org/0000-0001-7997-5027","observed_orcids":["https://orcid.org/0000-0001-7997-5027"]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Michel Grellard","raw_affiliation_strings":["Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Department Centre Fran\u00e7ois Baclesse, 14076, Caen, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003798935","display_name":"Antoine Thiery-Vuillemin","orcid":"https://orcid.org/0000-0001-6822-3401","observed_orcids":["https://orcid.org/0000-0001-6822-3401"]},"institutions":[{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Antoine Thiery-Vuillemin","raw_affiliation_strings":["Medical Oncology Department, CHRU Besan\u00e7on H\u00f4pital Jean Minjoz, 25030, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, CHRU Besan\u00e7on H\u00f4pital Jean Minjoz, 25030, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5057264839"],"corresponding_institution_ids":["https://openalex.org/I4210121964"],"apc_list":{"value":2790,"currency":"USD","value_usd":2790},"apc_paid":{"value":2790,"currency":"USD","value_usd":2790},"fwci":2.289,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.87848898,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"22","issue":"1","first_page":"1213","last_page":"1213"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.032099999487400055,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.968999981880188},{"id":"https://openalex.org/keywords/talazoparib","display_name":"talazoparib","score":0.9419999718666077},{"id":"https://openalex.org/keywords/avelumab","display_name":"avelumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.9490000009536743},{"id":"https://openalex.org/keywords/platinum-sensitive-disease","display_name":"platinum-sensitive disease","score":0.6679999828338623},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7120000123977661},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9390000104904175},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.8930000066757202},{"id":"https://openalex.org/keywords/dna-repair-deficiency","display_name":"DNA repair deficiency","score":0.972000002861023},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5519999861717224},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8510000109672546},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.621999979019165},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6610000133514404}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8430758714675903},{"id":"https://openalex.org/C2777381376","wikidata":"https://www.wikidata.org/wiki/Q21083261","display_name":"Avelumab","level":5,"score":0.8051648139953613},{"id":"https://openalex.org/C2911057145","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Metastatic Urothelial Carcinoma","level":5,"score":0.7075947523117065},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7023257613182068},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.657958984375},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.592153787612915},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5920630097389221},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.48820072412490845},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4565337598323822},{"id":"https://openalex.org/C2780140570","wikidata":"https://www.wikidata.org/wiki/Q3545481","display_name":"Surgical oncology","level":2,"score":0.42971283197402954},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3389798402786255},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.30163440108299255},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2775343656539917},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.17934522032737732},{"id":"https://openalex.org/C3019882237","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial carcinoma","level":4,"score":0.17121893167495728}],"mesh":[{"descriptor_ui":"D000067856","descriptor_name":"Poly(ADP-ribose) Polymerase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D002295","descriptor_name":"Carcinoma, Transitional Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002295","descriptor_name":"Carcinoma, Transitional Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010984","descriptor_name":"Platinum","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1186/s12885-022-10216-z","doi":"https://doi.org/10.1186/s12885-022-10216-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-022-10216-z","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-022-10216-z","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},{"id":"pmid:36434554","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36434554","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC cancer","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pubmedcentral.nih.gov:9700963","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9700963/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"Text"},{"id":"pmh:oai:HAL:hal-05743334v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-05743334","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Cancer, 2022, 22 (1), pp.1213. ⟨10.1186/s12885-022-10216-z⟩","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:acfbd3288d034b809da2abcad858ad21","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/acfbd3288d034b809da2abcad858ad21","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12885-022-10216-z","doi":"https://doi.org/10.1186/s12885-022-10216-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-022-10216-z","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-022-10216-z","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4310045802.pdf","grobid_xml":"https://content.openalex.org/works/W4310045802.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W2581231749","https://openalex.org/W2592941899","https://openalex.org/W2891749509","https://openalex.org/W2902946687","https://openalex.org/W2921480061","https://openalex.org/W2961496023","https://openalex.org/W2962822814","https://openalex.org/W2995672471","https://openalex.org/W3013900427","https://openalex.org/W3016461381","https://openalex.org/W3023288864","https://openalex.org/W3034529377","https://openalex.org/W3069915980","https://openalex.org/W3080421257","https://openalex.org/W3087464965","https://openalex.org/W3088003217","https://openalex.org/W3155705538","https://openalex.org/W3158712737","https://openalex.org/W3164048465","https://openalex.org/W4200128746","https://openalex.org/W4212895261","https://openalex.org/W4213209893","https://openalex.org/W4290879671","https://openalex.org/W4298025629","https://openalex.org/W7214149701"],"related_works":["https://openalex.org/W4402565924","https://openalex.org/W3137251658","https://openalex.org/W4386201115","https://openalex.org/W2586222551","https://openalex.org/W7084265519","https://openalex.org/W7136585296","https://openalex.org/W4205638399","https://openalex.org/W3087464965","https://openalex.org/W3041320125","https://openalex.org/W4386466678"],"abstract_inverted_index":{"BACKGROUND:":[0],"Urothelial":[1],"carcinoma":[2],"(UC)":[3],"is":[4,21,150,196,231],"the":[5,22,87,163,178,206,210,234,237,250,280,326],"ninth":[6],"most":[7],"commonly":[8],"diagnosed":[9],"cancer":[10],"worldwide,":[11],"with":[12,31,106,214,218,310,335],"a":[13,36,197,300],"3.8/1":[14],"male":[15],"to":[16,96,152,155,176,204,232,262],"female":[17],"ratio.":[18],"Platinum-based":[19],"chemotherapy":[20,158],"first":[23,100,331],"line":[24,101,332],"standard":[25,46],"of":[26,43,130,165,180,209,212,236,249,255,266,283],"care":[27],"for":[28,40,104,128],"fit":[29],"patients":[30,44,105,131,217,304],"advanced":[32,108],"UC.":[33],"However,":[34,120],"despite":[35],"response":[37,125],"rate":[38],"(RR)":[39],"approximately":[41],"half":[42],"receiving":[45],"chemotherapy,":[47],"durable":[48],"responses":[49],"are":[50,244],"rare":[51],"(median":[52],"progression-free":[53],"progression":[54,122],"(PFS)":[55],"around":[56],"8":[57],"months).":[58],"Recently,":[59],"immune":[60],"checkpoint":[61],"inhibitors":[62,169,185],"(ICI)":[63],"have":[64,113,314],"emerged":[65],"as":[66,99,123,134,186,245],"new":[67],"therapeutic":[68],"options.":[69],"Among":[70],"them,":[71],"Avelumab,":[72],"an":[73,82,336],"anti-PD-L1":[74],"antibody,":[75],"was":[76,126],"assessed":[77,239],"in":[78,86,189,222,299,329],"maintenance":[79,102,135,187,223,333],"treatment,":[80],"demonstrating":[81],"overall":[83],"survival":[84],"improvement":[85],"JAVELIN":[88],"Bladder-100":[89],"phase":[90,200],"III":[91],"trial.":[92],"These":[93],"findings":[94],"led":[95],"its":[97],"approval":[98],"therapy":[103,224,282],"locally":[107,219],"or":[109],"metastatic":[110],"UC":[111,137,190,221,330],"who":[112],"not":[114],"progressed":[115],"on":[116,294],"prior":[117],"platinum-containing":[118],"chemotherapy.":[119,227],"disease":[121,258],"best":[124],"noticed":[127],"37%":[129],"under":[132],"Avelumab":[133,213,291,311],"treatment.":[136],"has":[138],"targetable":[139],"genomic":[140],"alterations,":[141],"including":[142],"DNA":[143],"damage":[144],"repair":[145],"(DDR)":[146],"alterations.":[147],"DDR":[148],"deficiency":[149],"known":[151],"major":[153],"sensitivity":[154],"both":[156],"platinum-based":[157,226],"and":[159,162,167,270,289,297],"PD-1/PD-L1":[160],"blockade":[161],"combination":[164,211,281,312,323],"ICI":[166,182],"PARP":[168,184],"showed":[170],"promising":[171],"results.":[172],"It":[173],"therefore":[174],"warrants":[175],"assess":[177,205],"interest":[179],"combining":[181],"plus":[183],"treatment":[188],"patients.":[191],"METHODS:":[192],"The":[193,228],"TALASUR":[194],"trial":[195],"single-arm":[198],"multicenter":[199],"2":[201],"study":[202],"aiming":[203],"antitumor":[207,327],"activity":[208,316,328],"Talazoparib":[215,286,309],"among":[216],"advanced/metastatic":[220],"after":[225],"primary":[229],"objective":[230,252],"determine":[233],"efficacy":[235],"combination,":[238],"through":[240],"PFS.":[241],"Secondary":[242],"objectives":[243],"follows:":[246],"safety":[247,338],"profile":[248],"association,":[251],"response,":[253,257],"duration":[254],"tumoral":[256],"control":[259],"rate,":[260],"time":[261],"subsequent":[263],"therapy,":[264],"quality":[265],"life.":[267],"A":[268],"blood":[269],"tumor":[271],"collections":[272],"will":[273,278,305,324],"be":[274,306],"also":[275],"constituted.":[276],"Patient":[277],"receive":[279],"daily":[284],"oral":[285],"(1":[287],"mg/day)":[288],"intra-venous":[290],"800":[292],"mg":[293],"days":[295],"1":[296],"15,":[298],"28-day":[301],"cycle.":[302],"Fifty":[303],"enrolled.":[307],"DISCUSSION:":[308],"may":[313],"additive":[315],"when":[317],"administrated":[318],"jointly.":[319],"We":[320],"hypothesize":[321],"that":[322],"increase":[325],"setting":[334],"acceptable":[337],"profile.":[339],"TRIAL":[340],"REGISTRATION:":[341],"NCT04678362,":[342],"registered":[343],"December":[344],"21,":[345],"2020.":[346],"PROTOCOL":[347],"VERSION:":[348],"Version":[349],"1.3":[350],"dated":[351],"from":[352],"2020":[353],"09":[354],"11.":[355]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2022-11-30T00:00:00"}